Cargando…
Comparing ARIA‐E severity scales and effects of treatment management thresholds
INTRODUCTION: Amyloid‐related imaging abnormalities–edema (ARIA‐E) is associated with anti‐amyloid beta monoclonal antibody treatment. ARIA‐E severity may be assessed using the Barkhof Grand Total Scale (BGTS) or the 3‐ or 5‐point Severity Scales of ARIA‐E (SSAE‐3/SSAE‐5). We assessed inter‐ and int...
Autores principales: | Klein, Gregory, Scelsi, Marzia A., Barakos, Jerome, Fiebach, Jochen B., Bracoud, Luc, Suhy, Joyce, Delmar, Paul, Lyons, Marco, Wojtowicz, Jakub, Bullain, Szofia, Barkhof, Frederik, Purcell, Derk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716634/ https://www.ncbi.nlm.nih.gov/pubmed/36474747 http://dx.doi.org/10.1002/dad2.12376 |
Ejemplares similares
-
Validation of 3‐ and 5‐point severity scales to assess ARIA‐E
por: Bracoud, Luc, et al.
Publicado: (2023) -
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
por: Salloway, Stephen, et al.
Publicado: (2021) -
Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis
por: Arrighi, H Michael, et al.
Publicado: (2016) -
In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model
por: Aldea, Roxana, et al.
Publicado: (2022) -
Concert arias . opera arias
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1984)